Rep. Ayanna Pressley endorses Sen. Warren for president, splitting with rest of 'the squad.'
In a video she tweeted Wednesday, Pressley said that “big structural change can’t wait” and applauded Warren's myriad policy proposals, saying “the plans are about power.”
Pressley's is arguably the most high-profile endorsement Warren has earned thus far. The senator stayed out of Massachusetts' 2018 Democratic primary, declining to support a fellow member of the congressional delegation in favor of staying neutral. Pressley, a former Hillary Clinton surrogate who spent 16 years as a staffer for some of the biggest names in Massachusetts politicsPressley will campaign with Warren in North Carolina this week, Pressley’s chief of staff confirmed to NBC News.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Warren won't back down on taxing billionaires to cancel student debt, despite Leon Cooperman blastDemocratic presidential candidate Elizabeth Warren lashed out at billionaire Leon Cooperman on Monday for his stake in the student loan servicer Navient and stressed the importance of forgiving student debt.
Read more »
Opinion | Warren Asks What the Country Can Do for YouFrom WSJopinion: Elizabeth Warren fears that voters aren’t willing to pay a dime for 'Medicare for All,' writes chrisjacobsHC
Read more »
Billionaire Leon Cooperman Escalates Feud With Elizabeth Warren
Read more »
Warren pledges to overturn military transgender ban on Day 1Elizabeth Warren Tuesday released a detailed plan to tackle the needs of the military and veterans that pledges to roll back Trump administration policies that bar transgender troops and to not deport non-citizens who have served in uniform, or their families. The Massachusetts senator who is seeking
Read more »
If Warren Scraps Private Health Care, Beware the Unintended ConsequencesSen. Elizabeth Warren’s Medicare for All plan risks unintended consequences such as overuse of health care, fewer breakthrough drugs and potentially fewer doctors serving patients.
Read more »